In multiple cases, miR-191 influences tumor progression by regulating proliferation; miR-191 promotes proliferation in hepatocellular carcinoma, and in gastric carcinoma by targeting NDST1, but inhibits proliferation in thyroid carcinoma by targeting CDK6 [18, 20]. The gene discussed is CDK6; the disease is thyroid gland carcinoma.